United States Healthcare Equipment & Supplies

Bluejay Diagnostics Inc (BJDX)

Track

Track

Bluejay Diagnostics experienced two recent transactions by HRT Financial LP, resulting in a net positive value of $47,797.77. Despite these activities, the stock price declined 36.5% over the last quarter. No executive-level buying occurred during this period, following the company's latest results financiers.
Ticker: BJDX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bluejay Diagnostics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Sale
Price
299.38
Quantity 31,267 -26.7%
Value US$2,896,331
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Purchase
Price
239.57
Quantity 256 +37.9%
Value US$2,713,282
1.5
CHASE DONALD R Non-Executive Director
Transaction date
Purchase
Price
122.62
Quantity 56,593 -41.8%
Value US$2,686,704
2.2
Wurth Douglas Clark Non-Executive Director
Transaction date
Purchase
Price
2.00
Quantity 12,500 +11574.1%
Value US$25,000
2.0
Dey Indranil President and CEO Executive Director
Transaction date
Purchase
Price
2.00
Quantity 12,500 +56818.2%
Value US$25,000
2.2
Dey Svetlana Non-Executive Director
Transaction date
Purchase
Price
2.00
Quantity 12,500 +1250000.0%
Value US$25,000
1.5
ZEIDMAN FRED S Non-Executive Director
Transaction date
Purchase
Price
2.00
Quantity 12,500 +inf%
Value US$25,000
2.2
Dey Svetlana Non-Executive Director
Transaction date
Purchase
Price
3.07
Quantity 500 +50.0%
Value US$1,535
2.0
Dey Indranil President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.27
Quantity 500 +1.8%
Value US$1,635
3.0
Fisher Kenneth R Chief Financial Officer Officer
Transaction date
Purchase
Price
1.03
Quantity 20,000 +100.0%
Value US$20,600
3.0
Fisher Kenneth R Chief Financial Officer Officer
Transaction date
Purchase
Price
0.99
Quantity 20,000 +inf%
Value US$19,800
2.2
Dey Svetlana Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.18
Quantity 10,000 +inf%
Value US$11,830
2.9
Kinder Gordon Winston Chief Financial Officer Officer
Transaction date
Purchase
Price
1.16
Quantity 2,500 +15.6%
Value US$2,898
2.2
Wurth Douglas Clark Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.18
Quantity 40,000 +1.8%
Value US$47,120
2.2
Wurth Douglas Clark Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.09
Quantity 60,000 +2.7%
Value US$65,400
2.9
Kinder Gordon Winston Chief Financial Officer Officer
Transaction date
Purchase
Price
1.02
Quantity 5,000 +45.5%
Value US$5,100
2.9
Kinder Gordon Winston Chief Financial Officer Officer
Transaction date
Purchase
Price
0.91
Quantity 500 +4.8%
Value US$455
2.9
Kinder Gordon Winston Chief Financial Officer Officer
Transaction date
Purchase
Price
0.95
Quantity 10,500 +inf%
Value US$9,975
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-13 2026-07-10 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
31,267 -26.7%
299.38
US$2,896,331 		31,267 -26.7% 299.38 US$2,896,331
2026-07-13 2026-07-09 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
256 +37.9%
239.57
US$2,713,282 		256 +37.9% 239.57 US$2,713,282
2026-05-18 2026-03-14 B Purchase
1.5
CHASE DONALD R
Non-Executive Director
56,593 -41.8%
122.62
US$2,686,704 		56,593 -41.8% 122.62 US$2,686,704
2026-05-18 2026-03-14 B Purchase
2.2
Wurth Douglas Clark
Non-Executive Director
12,500 +11574.1%
2.00
US$25,000 		12,500 +11574.1% 2.00 US$25,000
2026-05-18 2026-03-14 B Purchase
2.0
Dey Indranil

President and CEO

Executive Director
12,500 +56818.2%
2.00
US$25,000 		12,500 +56818.2% 2.00 US$25,000
2026-05-18 2026-03-14 B Purchase
2.2
Dey Svetlana
Non-Executive Director
12,500 +1250000.0%
2.00
US$25,000 		12,500 +1250000.0% 2.00 US$25,000
2026-05-18 2026-03-14 B Purchase
1.5
ZEIDMAN FRED S
Non-Executive Director
12,500 +inf%
2.00
US$25,000 		12,500 +inf% 2.00 US$25,000
2023-12-14 2023-12-13 B Purchase
2.2
Dey Svetlana
Non-Executive Director
500 +50.0%
3.07
US$1,535 		500 +50.0% 3.07 US$1,535
2023-12-14 2023-12-13 B Purchase
2.0
Dey Indranil

President and CEO

Executive Director Large shareholder
500 +1.8%
3.27
US$1,635 		500 +1.8% 3.27 US$1,635
2022-09-07 2022-08-26 B Purchase
3.0
Fisher Kenneth R

Chief Financial Officer

Officer
20,000 +100.0%
1.03
US$20,600 		20,000 +100.0% 1.03 US$20,600
2022-04-27 2022-04-25 B Purchase
3.0
Fisher Kenneth R

Chief Financial Officer

Officer
20,000 +inf%
0.99
US$19,800 		20,000 +inf% 0.99 US$19,800
2022-03-21 2022-03-17 B Purchase
2.2
Dey Svetlana
Non-Executive Director Large shareholder
10,000 +inf%
1.18
US$11,830 		10,000 +inf% 1.18 US$11,830
2022-03-21 2022-03-17 B Purchase
2.9
Kinder Gordon Winston

Chief Financial Officer

Officer
2,500 +15.6%
1.16
US$2,898 		2,500 +15.6% 1.16 US$2,898
2022-03-18 2022-03-17 B Purchase
2.2
Wurth Douglas Clark
Non-Executive Director Large shareholder
40,000 +1.8%
1.18
US$47,120 		40,000 +1.8% 1.18 US$47,120
2022-03-17 2022-03-16 B Purchase
2.2
Wurth Douglas Clark
Non-Executive Director Large shareholder
60,000 +2.7%
1.09
US$65,400 		60,000 +2.7% 1.09 US$65,400
2022-03-16 2022-03-16 B Purchase
2.9
Kinder Gordon Winston

Chief Financial Officer

Officer
5,000 +45.5%
1.02
US$5,100 		5,000 +45.5% 1.02 US$5,100
2022-03-16 2022-03-15 B Purchase
2.9
Kinder Gordon Winston

Chief Financial Officer

Officer
500 +4.8%
0.91
US$455 		500 +4.8% 0.91 US$455
2022-03-16 2022-03-14 B Purchase
2.9
Kinder Gordon Winston

Chief Financial Officer

Officer
10,500 +inf%
0.95
US$9,975 		10,500 +inf% 0.95 US$9,975
Explore more

More insider trading research around Bluejay Diagnostics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America